Evonik (EVK GY) FY (EUR) Sales 14.1bln (exp. 14bln), Adj. EBITDA 1.87bln (exp. 1.87bln). FY Outlook: Adj. EBITDA 1.7-2bln (exp. 1.84bln)

Evonik's FY sales slightly beat expectations, which may indicate solid underlying demand.

Newsquawk StaffPublished On the live feed at 8 more headlines followed before this page went public
Newsquawk headlinesUTC

Nio (NIO / 9866 HK) Q4 Prelim (USD): Adj. Profit 100-172mln (prev. -798.3mln Y/Y); profit alert

EU Commission finds that Apple (AAPL) ads and Apple maps should not be designated under the Digital Markets Act

Evonik (EVK GY) FY (EUR) Sales 14.1bln (exp. 14bln), Adj. EBITDA 1.87bln (exp. 1.87bln). FY Outlook: Adj. EBITDA 1.7-2bln (exp. 1.84bln)

[MARKET UPDATE] DXY continues grinding higher after topping resistance around the 97.70-97.75 area, with current session high at 97.89; clean air seen until the next resistance at 98.48 (23rd Jan high)

Spain sells EUR 5.838bln vs exp. EUR 5-6bln 2.35% 2029, 3.00% 2033, 3.20% 2035 Bono and EUR 0.646bln vs exp. EUR 0.25-0.75bln 0.70% 2033 IL

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

However, the FY outlook for adjusted EBITDA falls short of consensus, suggesting potential headwinds that could impact future profitability. This mixed performance might signal caution among investors, as the decreased guidance contrasts with their current results.

Related headlines

The whole workspace, free to try.

Try it free